U.S. Markets
Gilead Sciences Inc. (GILD) Q3 2026 (USD) Adj. EPS 2.55 (exp. 2.19), Revenue 8.30bln (exp. 7.80bln)
ORIGINAL · NewsquawkGilead Sciences Inc. (GILD) Q3 2026 (USD) Adj. EPS 2.55 (exp. 2.19), Revenue 8.30bln (exp. 7.80bln)Read originalHide original
Sees FY Adj. loss/shr 0.85-1.20 (exp. loss 0.40)
StockNow breaking-news AI analysis
Gilead reported Q3 adjusted EPS and revenue above stated expectations, while its FY adjusted loss-per-share outlook was a loss of $0.85–$1.20.
News detail
Sees FY Adj. loss/shr 0.85-1.20 (exp. loss 0.40)
Related stocks
1 stocks
What do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.